Aeluma, Inc. (ALMU) - 10-Q Filing Summary
Business Context and Reporting Period
This summary covers the quarterly report on Form 10-Q for Aeluma, Inc. for the period ended March 31, 2026. Aeluma is a development-stage semiconductor company specializing in high-performance optoelectronic and electronic devices using compound semiconductors on large-diameter substrates. The company operates R&D and manufacturing facilities in Goleta, California, and generates revenue primarily through government contracts (NASA, DoD, DOE) and commercial product/service agreements.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2026 | Balance Sheet (Mar 31, 2026) |
|---|---|---|---|
| Revenue | $1.22 million | $3.88 million | - |
| Net Loss | $(1.80) million | $(5.15) million | - |
| Operating Loss | $(2.13) million | $(5.81) million | - |
| Cash & Equivalents | - | - | $37.78 million |
| Total Assets | - | - | $42.52 million |
| Total Liabilities | - | - | $2.43 million |
| Stockholders' Equity | - | - | $40.09 million |
| Net Cash Used in Operations | - | $(1.64) million | - |
Note: The filing does not explicitly state gross or operating margins as percentages; however, Cost of Revenue was $0.84 million for the quarter and $2.46 million for the nine months.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 16% year-over-year for the nine months ended March 31, 2026 ($3.88M vs. $3.35M), driven by government contracts.
- Expense Expansion: Operating expenses surged 114% to $9.69 million for the nine-month period, primarily due to increased material purchases for revenue delivery and higher compensation costs (including stock-based compensation) from hiring to support business scaling.
- Net Loss Increase: Net loss widened to $5.15 million for the nine months ended March 31, 2026, compared to $2.16 million in the prior year period. This was exacerbated by the removal of non-cash gains from derivative liabilities and convertible note amortization that benefited the prior year.
- Liquidity Improvement: Cash and cash equivalents increased significantly to $37.78 million from $15.74 million at the start of the fiscal year, largely due to net proceeds of $23.4 million from a public offering in September 2025.
Outlook, Risks, and Management Commentary
- Capital Resources: Management maintains a strong liquidity position with $37.8 million in cash. On March 20, 2026, the company entered an "at-the-market" sales agreement to sell up to $50 million of common stock, though no sales had occurred as of the period end.
- Government Contracts: The company secured new material government contracts totaling $2.3 million in the quarter and $2.5 million in the nine months. Remaining performance obligations under government contracts totaled $8.9 million as of March 31, 2026.
- Operational Expansion: Headcount increased with the addition of eight qualified personnel. The company leased an additional 2,400 sq. ft. office space in September 2025 to support growth.
- Risk Factors:
- Government Shutdown: A prolonged U.S. federal government shutdown could materially adversely affect revenue, operations, and legal proceedings given the reliance on government agencies.
- Customer Concentration: Revenue is highly concentrated; for the nine months ended March 31, 2026, 68% and 15% of revenue came from two customers (all government agencies).
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2026, citing insufficient staffing in the finance department to support reporting complexity.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and progress of hiring additional accounting personnel to remediate the ineffective disclosure controls.
- Government Contract Stability: Assess the risk of revenue disruption due to potential federal government shutdowns or budget negotiations, given the high concentration of government customers.
- Burn Rate vs. Cash Runway: Monitor the rate of cash consumption against the $37.8 million cash balance to determine the runway before additional financing is required.
- Commercialization Progress: Track the transition from R&D/government contracts to scalable commercial product sales to validate the path to profitability.